These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 1495285

  • 1. The determinants of elevated total plasma cholesterol levels in cardiac transplant recipients administered low dose cyclosporine for immunosuppression.
    Laufer G, Grablowitz V, Laczkovics A, Miholic J, Heinz G, Wollenek G, Schreiner W, Wolfram J, Wolner E.
    J Thorac Cardiovasc Surg; 1992 Aug; 104(2):241-7. PubMed ID: 1495285
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of low dose simvastatin in cardiac transplant recipients treated with cyclosporine.
    Vanhaecke J, Van Cleemput J, Van Lierde J, Daenen W, De Geest H.
    Transplantation; 1994 Jul 15; 58(1):42-5. PubMed ID: 8036706
    [Abstract] [Full Text] [Related]

  • 3. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study.
    Fernández-Miranda C, de la Calle A, Morales JM, Guijarro C, Aranda JL, Gómez-Sanz R, Gómez-Izquierdo T, Larumbe S, Moreno E, Rodicio JL, del Palacio A.
    Clin Transplant; 1998 Apr 15; 12(2):136-41. PubMed ID: 9575402
    [Abstract] [Full Text] [Related]

  • 4. The impact of steroid withdrawal on the development of lipid abnormalities and obesity in heart transplant recipients.
    Lake KD, Reutzel TJ, Pritzker MR, Jorgensen CR, Emery RW.
    J Heart Lung Transplant; 1993 Apr 15; 12(4):580-90. PubMed ID: 8369320
    [Abstract] [Full Text] [Related]

  • 5. Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy.
    Charco R, Cantarell C, Vargas V, Capdevila L, Lázaro JL, Hidalgo E, Murio E, Margarit C.
    Liver Transpl Surg; 1999 May 15; 5(3):204-8. PubMed ID: 10226111
    [Abstract] [Full Text] [Related]

  • 6. Association between isolated hypercholesterolemia, isolated hypertriglyceridemia and coronary artery disease in south Indian type 2 diabetic patients.
    Rajmohan L, Deepa R, Mohan A, Mohan V.
    Indian Heart J; 2000 May 15; 52(4):400-6. PubMed ID: 11084779
    [Abstract] [Full Text] [Related]

  • 7. Independent risk factors predicting acute graft rejection in cardiac transplant recipients treated by triple drug immunosuppression.
    Laufer G, Miholic J, Laczkovics A, Wollenek G, Holzinger C, Hajek-Rosenmeier A, Wuzl G, Schreiner W, Buxbaum P, Wolner E.
    J Thorac Cardiovasc Surg; 1989 Dec 15; 98(6):1113-21. PubMed ID: 2586129
    [Abstract] [Full Text] [Related]

  • 8. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M, McNicoll S, Marcil M, Connelly P, Lussier-Cacan S, Davignon J, Latour Y, Genest J.
    Can J Cardiol; 1997 Mar 15; 13(3):253-60. PubMed ID: 9117913
    [Abstract] [Full Text] [Related]

  • 9. Hyperlipidemia in long-term survivors of pediatric renal transplantation.
    Sharma AK, Myers TA, Hunninghake DB, Matas AJ, Kashtan CE.
    Clin Transplant; 1994 Jun 15; 8(3 Pt 1):252-7. PubMed ID: 8061364
    [Abstract] [Full Text] [Related]

  • 10. Correlation of C0 and C2 levels with lipid profiles in adolescent renal transplant recipients in the early and late posttransplant periods.
    Soylu A, Kavukçu S, Türkmen MA, Kasap B, Soylu A, Bora S, Gülay H.
    Transplant Proc; 2006 Jun 15; 38(5):1286-9. PubMed ID: 16797283
    [Abstract] [Full Text] [Related]

  • 11. A long-term study on hyperlipidemia in stable renal transplant recipients.
    Tse KC, Lam MF, Yip PS, Li FK, Lai KN, Chan TM.
    Clin Transplant; 2004 Jun 15; 18(3):274-80. PubMed ID: 15142048
    [Abstract] [Full Text] [Related]

  • 12. Hypercholesterolemia is common after pediatric heart transplantation: initial experience with pravastatin.
    Seipelt IM, Crawford SE, Rodgers S, Backer C, Mavroudis C, Seipelt RG, Pahl E.
    J Heart Lung Transplant; 2004 Mar 15; 23(3):317-22. PubMed ID: 15019641
    [Abstract] [Full Text] [Related]

  • 13. Initial steroid-free versus steroid-based maintenance therapy and steroid withdrawal after heart transplantation: two views of the steroid question.
    Keogh A, Macdonald P, Harvison A, Richens D, Mundy J, Spratt P.
    J Heart Lung Transplant; 1992 Mar 15; 11(2 Pt 2):421-7. PubMed ID: 1571340
    [Abstract] [Full Text] [Related]

  • 14. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW, Huff M, Oskalns R, Rudas L, Kostuk WJ.
    J Heart Lung Transplant; 1995 Mar 15; 14(4):613-22. PubMed ID: 7578166
    [Abstract] [Full Text] [Related]

  • 15. Ischemic heart disease after renal transplantation in patients on cyclosporine in Spain.
    Marcén R, Morales JM, Arias M, Fernández-Juárez G, Fernández-Fresnedo G, Andrés A, Rodrigo E, Pascual J, Domínguez B, Ortuño J.
    J Am Soc Nephrol; 2006 Dec 15; 17(12 Suppl 3):S286-90. PubMed ID: 17130276
    [Abstract] [Full Text] [Related]

  • 16. New-onset cardiovascular risk factors in lung transplant recipients.
    Silverborn M, Jeppsson A, Mårtensson G, Nilsson F.
    J Heart Lung Transplant; 2005 Oct 15; 24(10):1536-43. PubMed ID: 16210127
    [Abstract] [Full Text] [Related]

  • 17. Hypercholesterolemia after heart transplantation: amelioration by corticosteroid-free maintenance immunosuppression.
    Renlund DG, Bristow MR, Crandall BG, Burton NA, Doty DB, Karwande SV, Gay WA, Jones KW, Hegewald MG, Hagan ME.
    J Heart Transplant; 1989 Oct 15; 8(3):214-9; discussion 219-20. PubMed ID: 2661771
    [Abstract] [Full Text] [Related]

  • 18. Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia.
    Almutairi F, Peterson TC, Molinari M, Walsh MJ, Alwayn I, Peltekian KM.
    Liver Transpl; 2009 May 15; 15(5):504-8. PubMed ID: 19399742
    [Abstract] [Full Text] [Related]

  • 19. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM, Canafax DM, Gillingham KJ, Humar A, Pandian K, Kerr SR, Najarian JS, Matas AJ.
    Clin Transplant; 1997 Dec 15; 11(6):552-7. PubMed ID: 9408683
    [Abstract] [Full Text] [Related]

  • 20. Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis.
    Chueh SC, Kahan BD.
    Transplantation; 2003 Jul 27; 76(2):375-82. PubMed ID: 12883196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.